PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Propanc Biopharma, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$0.32−0.03 (-7.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| May 18, 2026 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Feb 14, 2025(first seen in filings) | 1-for-59983 reverse | Earlier per-share figures multiplied by 59983 |
| Jan 29, 2025 | 1-for-2 reverse | Earlier per-share figures multiplied by 2 |
| Nov 19, 2020 | 1-for-1000 reverse | Earlier per-share figures multiplied by 1000 |
| Oct 15, 2019(first seen in filings) | 1-for-500 reverse | Earlier per-share figures multiplied by 500 |
| Jun 24, 2019 | 1-for-500 reverse | Earlier per-share figures multiplied by 500 |
| May 8, 2017(first seen in filings) | 1-for-250 reverse | Earlier per-share figures multiplied by 250 |
| Apr 20, 2017 | 1-for-250 reverse | Earlier per-share figures multiplied by 250 |